| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 60,198 | 59,325 | 41,099 | 43,733 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 59,325 | 41,099 | 43,733 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 113,133 | 3,912 | 58,088 | 29,678 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (53,688) | 55,413 | (16,989) | 14,055 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,867) | (3,262) | 5,129 |
-
| | Earnings Before Interest And Taxes | (54,802) | 52,151 | (11,860) | 14,055 | | Interest Expense | (54,900) | 54,636 | 1,017 | 29,722 | | Income Before Tax | 98 | (2,485) | (12,877) | (15,667) | | Income Tax Expense | 34 | (857) | (4,443) | (12,941) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 64 | (1,628) | (8,434) | (2,726) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 64 | (1,628) | (8,434) | (2,726) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $64 | ($1,628) | ($8,434) | ($2,726) |
|
0.51% Nasdaq 
0.07 (0.71%) 
Income Statement
